Biotech · Private company
AiCuris Anti-infective Cures AG
Track this companyFree. Adds AiCuris Anti-infective Cures AG to your Dealase workspace and tells you when its record changes.
Clinical trials61 recruiting or active
Pipeline programs9From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline9
- Investigator's choicePhase 3 · HSV InfectionClinicalTrials.gov · fetched Nov 12, 2026
- PritelivirPhase 3 · HSV InfectionClinicalTrials.gov · fetched Nov 12, 2026
- AIC263029Phase 2 · BK Virus InfectionClinicalTrials.gov · fetched Nov 12, 2026
- AIC316Phase 2 · HSV-2ClinicalTrials.gov · fetched Nov 12, 2026
- AIC316Phase 2 · Genital HerpesClinicalTrials.gov · fetched Nov 12, 2026
- Pritelivir 5% w/w ointmentPhase 2 · Herpes LabialisClinicalTrials.gov · fetched Nov 12, 2026
- ValacyclovirPhase 2 · Genital HerpesClinicalTrials.gov · fetched Nov 12, 2026
- Zovirax® creamPhase 2 · Herpes LabialisClinicalTrials.gov · fetched Nov 12, 2026
- ESO and pritelivirPhase 1 · HSV InfectionClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- A Trial to Evaluate the Safety, Tolerability and Efficacy of AIC263029 in Kidney Transplant Recipients With BKV InfectionPHASE2 · RECRUITING · started Oct 5, 2026ClinicalTrials.gov NCT07503561 · fetched Nov 12, 2026
- Potential Influence of Esomeprazole on the Pharmacokinetics of PritelivirPHASE1 · COMPLETED · started Jul 13, 2020ClinicalTrials.gov NCT05513625 · fetched Nov 12, 2026
- Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised SubjectsPHASE3 · COMPLETED · started May 8, 2017ClinicalTrials.gov NCT03073967 · fetched Nov 12, 2026
- Trial on Efficacy and Safety of Pritelivir Ointment for Treatment of Labial HerpesPHASE2 · COMPLETED · started Nov 29, 2016ClinicalTrials.gov NCT02871492 · fetched Nov 12, 2026
- Safety and Efficacy Comparator Trial of a New Drug Against Genital HerpesPHASE2 · TERMINATED · started Oct 1, 2012ClinicalTrials.gov NCT01658826 · fetched Nov 12, 2026
- Safety and Efficacy Study for a New Antiviral Drug to Treat Genital Herpes Type 2PHASE2 · COMPLETED · started Mar 1, 2010ClinicalTrials.gov NCT01047540 · fetched Nov 12, 2026